erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the .
OFF DEAL
218 Used Today
OFF DEAL
1243 Used Today
884 Used Today
318 Used Today
254 Used Today
77 Used Today
38 Used Today
273 Used Today
323 Used Today